2/9
09:05 am
bngo
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
Low
Report
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
2/4
08:00 am
bngo
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
Medium
Report
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
1/12
08:00 am
bngo
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
Low
Report
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
12/11
08:27 am
bngo
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 [Yahoo! Finance]
Low
Report
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 [Yahoo! Finance]
12/11
08:00 am
bngo
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
Low
Report
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
12/3
08:23 am
bngo
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]
Medium
Report
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]
12/3
08:00 am
bngo
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
Low
Report
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
11/24
07:19 am
bngo
Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/14
01:11 pm
bngo
Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:37 am
bngo
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]
Low
Report
Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]